Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma

Stem Cells

Volumn 28, Issue 5, 2010, Pages 851-862

  Pistollato, Francesca ^a   Abbadi, Sara ^a   Rampazzo, Elena ^a   Persano, Luca ^a   Della Puppa, Alessandro ^a   Frasson, Chiara ^a   Sarto, Eva ^a   Scienza, Renato ^a   D'Avella, Domenico ^a   Basso, Giuseppe ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cancer stem cells; Glioblastoma; Hypoxia; O6 methylguanine DNA methyltransferase; Smad1 5 8; Stat3; Temozolomide

Indexed keywords

BETA TUBULIN; CD133 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; STAT3 PROTEIN; TEMOZOLOMIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL HETEROGENEITY; CELL HYPOXIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 77952330272     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.415     Document Type: Article

References (45)

1. Louis DN, Ohgaki H, Wiestler OD et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109. (Pubitemid 47103521)
2. Altaner C. Glioblastoma and stem cells. Neoplasma 2008;55:369-374.
3. Higa GM, Abraham J. Biological mechanisms of bevacizumab-associated adverse events. Expert Rev Anticancer Ther 2009;9:999-1007.
4. Sanchez-Martin M. Brain tumour stem cells: Implications for cancer therapy and regenerative medicine. Curr Stem Cell Res Ther 2008;3:197-207.
5. Beier D, Rohrl S, Pillai DR et al. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res 2008;68:5706-5715.
6. Liu G, Yuan X, Zeng Z et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006;5:67. (Pubitemid 44942887)
7. Murat A, Migliavacca E, Gorlia T et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008;26:3015-3024.
8. Chinot OL, Barrie M, Fuentes S et al. Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide. J Clin Oncol 2007;25:1470-1475. (Pubitemid 46733073)
9. Hegi ME, Diserens AC, Gorlia T et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352:997-1003. (Pubitemid 40349502)
10. Cao VT, Jung TY, Jung S et al. The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas. Neurosurgery 2009;65:866-875; Discussion 875.
11. Azuma Y, Chou SC, Lininger RA et al. Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: Pimonidazole and involucrin. Clin Cancer Res 2003;9:4944-4952. (Pubitemid 37323301)
12. Helczynska K, Kronblad A, Jogi A et al. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 2003;63:1441-1444. (Pubitemid 36373625)
13. Jogi A, Ora I, Nilsson H et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 2002;99:7021-7026. (Pubitemid 34526250)
14. Smith K, Gunaratnam L, Morley M et al. Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer. Cancer Res 2005;65:5221-5230. (Pubitemid 40827332)
15. Amberger-Murphy V. Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets 2009;9:381-390.
16. Gustafsson MV, Zheng X, Pereira T et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005;9:617-628. (Pubitemid 41555144)
17. Pistollato F, Chen HL, Rood BR et al. Hypoxia and HIF1alpha repress the differentiative effects of BMPs in high-grade glioma. Stem Cell. 2009;27:7-17.
18. Pistollato F, Rampazzo E, Abbadi S et al. Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells. Plos One 2009;4:e6206.
19. Li Z, Bao S, Wu Q et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009;15:501-513.
20. Soeda A, Park M, Lee D et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009;28:3949-3959.
21. Piccirillo SG, Combi R, Cajola L et al. Distinct pools of cancer stemlike cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution. Oncogene 2009;28:1807-1811.
22. Hegi ME, Liu L, Herman JG et al. Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 2008;26:4189-4199.
23. Schwartz PH, Bryant PJ, Fuja TJ et al. Isolation and characterization of neural progenitor cells from post-mortem human cortex. J Neurosci Res 2003;74:838-851. (Pubitemid 37490416)
24. Pistollato F, Chen HL, Schwartz PH et al. Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes. Mol Cell Neurosci 2007;35:424-435. (Pubitemid 46992832)
25. Viola G, Salvador A, Vedaldi D et al. Induction of apoptosis by photoexcited tetracyclic compounds derivatives of benzo[b]thiophenes and pyridines. J Photochem Photobiol B 2006;82:105-116. (Pubitemid 43091808)
26. Marin-Hernandez A, Gallardo-Perez JC, Ralph SJ et al. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 2009;9:1084-1101.
27. Liao SY, Lerman MI, Stanbridge EJ. Expression of transmembrane carbonic anhydrases, Caix And CAXII, in human development. BMC Dev Biol 2009;9:22.
28. Rempel SA, Golembieski WA, Ge S et al. SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J Neuropathol Exp Neurol 1998;57:1112-1121. (Pubitemid 28562739)
29. Perrin JS, Araneda S, Catteau J et al. Glial vascular endothelial growth factor overexpression in rat brainstem under tolerable hypoxia: Evidence for a central chemosensitivity. J Neurosci Res 2009;87:79-85.
30. Nakashima K, Yanagisawa M, Arakawa H et al. Astrocyte differentiation mediated by LIF in cooperation with BMP2. FEBS Lett 1999;457:43-46. (Pubitemid 29388176)
31. Galli R, Binda E, Orfanelli U et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-7021. (Pubitemid 39331011)
32. Hemmati HD, Nakano I, Lazareff JA et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003;100:15178-15183.
33. Reya T, Morrison SJ, Clarke MF et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
34. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401.
35. Yuan X, Curtin J, Xiong Y et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004;23:9392-9400.
36. Fu J, Liu ZG, Liu XM et al. Glioblastoma stem cells resistant to temozolomide-induced autophagy. Chin Med J (Engl) 2009;122:1255-1259.
37. McCord AM, Jamal M, Williams ES et al. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin Cancer Res 2009;15:5145-5153.
38. Panchision DM, Chen HL, Pistollato F et al. Optimized flow cytometric analysis of central nervous system tissue reveals novel functional relationships among cells expressing CD133, CD15, and CD24 Stem Cells 2007;25:1560-1570. (Pubitemid 47106026)
39. Schold SC Jr., Kokkinakis DM, Chang SM et al. O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas. Neuro Oncol 2004;6:28-32.
40. Spiro TP, Gerson SL, Liu L et al. O6-benzylguanine: A clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. Cancer Res 1999;59:2402-2410. (Pubitemid 29242289)
41. Calabrese C, Poppleton H, Kocak M et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007;11:69-82. (Pubitemid 46054518)
42. Gilbertson RJ, Rich JN. Making a tumour's bed: Glioblastoma stem cells and the vascular niche. Nat Rev Cancer 2007;7:733-736.
43. Heddleston JM, Li Z, Lathia JD et al. Hypoxia inducible factors in cancer stem cells. Br J Cancer 2;102:789-795.
44. Heddleston JM, Li Z, McLendon RE et al. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009;8:3274-3284.
45. Panchision DM. The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol 2009;220:562-568.